Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
6.41
-0.61 (-8.69%)
At close: Oct 23, 2026, 4:00 PM EDT
6.52
+0.11 (1.72%)
After-hours: Oct 23, 2026, 4:57 PM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $560.86 million as of October 23, 2026. It is the 13,029th most valuable company in the world and the 2,591st biggest in the United States. Its market cap has decreased by 0.22% in one year.
Market Cap
560.86M
Enterprise Value
103.45M
1-Year Change
-0.22%
Global Rank
Country Rank
#2,591 United States
Category
ChartMarket Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $560.86M, a decrease of -68.75%. That is a compound annual growth rate of -17.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 560.86M | -71.48% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 664.05M |
| Pharming Group | 658.29M |
| Avalo Therapeutics | 657.50M |
| Attovia Therapeutics | 647.33M |
| Candel Therapeutics | 640.46M |
| Gyre Therapeutics | 625.60M |
| Climb Bio | 624.33M |
| Zevra Therapeutics | 615.22M |